Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,448,542
  • Shares Outstanding, K 390,016
  • Annual Sales, $ 4,033 M
  • Annual Income, $ 576,200 K
  • EBIT $ 778 M
  • EBITDA $ 995 M
  • 60-Month Beta 1.51
  • Price/Sales 6.27
  • Price/Cash Flow 28.85
  • Price/Book 9.28

Options Overview Details

View History
  • Implied Volatility 33.25% (-3.25%)
  • Historical Volatility 58.47%
  • IV Percentile 16%
  • IV Rank 10.99%
  • IV High 77.57% on 10/30/25
  • IV Low 27.78% on 08/05/25
  • Expected Move (DTE 7) 3.06 (4.62%)
  • Put/Call Vol Ratio 0.11
  • Today's Volume 1,343
  • Volume Avg (30-Day) 11,359
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 195,049
  • Open Int (30-Day) 206,662
  • Expected Range 63.15 to 69.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.65
  • Number of Estimates 11
  • High Estimate 0.69
  • Low Estimate 0.59
  • Prior Year 0.45
  • Growth Rate Est. (year over year) +44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.11 +22.53%
on 11/07/25
66.53 -0.34%
on 12/05/25
+7.02 (+11.84%)
since 11/05/25
3-Month
54.11 +22.53%
on 11/07/25
79.65 -16.76%
on 09/08/25
-14.21 (-17.65%)
since 09/05/25
52-Week
54.11 +22.53%
on 11/07/25
93.25 -28.90%
on 02/18/25
-12.62 (-15.99%)
since 12/05/24

Most Recent Stories

More News
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM

NEW YORK , Dec. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).

DXCM : 66.46 (+1.85%)
Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

New personalised learning platform aims to build confidence in healthcare professional (HCP) CGM knowledge, no matter their previous experience, and support high-quality diabetes care. ...

DXCM : 66.46 (+1.85%)
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Dec. 4, 2025 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom"...

DXCM : 66.46 (+1.85%)
DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM

LOS ANGELES , Dec. 4, 2025 /PRNewswire/ --  The DJS Law Group  reminds investors of a class action lawsuit against  DexCom, Inc. ("DexCom " or "the Company") (NASDAQ: DXCM ) for violations...

DXCM : 66.46 (+1.85%)
3 Mid-Cap Stocks to Research Further

3 Mid-Cap Stocks to Research Further

HUM : 259.61 (+2.60%)
RIVN : 18.14 (+0.44%)
DXCM : 66.46 (+1.85%)
Is DexCom Stock Underperforming the S&P 500?

DexCom has considerably underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 6,876.68 (+0.29%)
PODD : 310.12 (-1.84%)
DXCM : 66.46 (+1.85%)
Stocks Settle Higher on Strength in Chip Makers and Boeing

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up by +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.84%. December...

MSTR : 179.58 (-3.46%)
TER : 201.27 (+1.33%)
AMAT : 270.33 (+0.33%)
ADI : 281.86 (+1.66%)
GLXY : 26.41 (-4.21%)
KHC : 24.72 (+0.53%)
MDB : 403.39 (+1.68%)
TXN : 183.74 (+2.01%)
$IUXX : 25,691.03 (+0.43%)
COIN : 269.22 (-1.76%)
ASML : 1,109.78 (-0.03%)
ZNH26 : 112-190 (-0.11%)
Stock Indexes Push Higher on Strength in Chip Makers

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.45%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.93%. December E-mini S&P futures...

TER : 201.27 (+1.33%)
AMAT : 270.33 (+0.33%)
MPC : 193.40 (+1.71%)
CVX : 152.44 (+0.12%)
MDB : 403.39 (+1.68%)
$IUXX : 25,691.03 (+0.43%)
ASML : 1,109.78 (-0.03%)
ZNH26 : 112-190 (-0.11%)
OXY : 43.13 (+1.08%)
ESZ25 : 6,885.50 (+0.27%)
GFS : 39.37 (+4.76%)
LRCX : 159.21 (+1.35%)
Stock Indexes Push Higher on Strength in Chip Makers

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.79%. December E-mini S&P futures...

TER : 201.27 (+1.33%)
AMAT : 270.33 (+0.33%)
MPC : 193.40 (+1.71%)
AVGO : 387.24 (+1.63%)
CVX : 152.44 (+0.12%)
MDB : 403.39 (+1.68%)
$IUXX : 25,691.03 (+0.43%)
DASH : 225.77 (+2.07%)
ASML : 1,109.78 (-0.03%)
ZNH26 : 112-190 (-0.11%)
OXY : 43.13 (+1.08%)
ESZ25 : 6,885.50 (+0.27%)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom Lawsuit - DXCM

NEW YORK , Dec. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

DXCM : 66.46 (+1.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 66.94
2nd Resistance Point 66.14
1st Resistance Point 65.69
Last Price 66.46
1st Support Level 64.45
2nd Support Level 63.65
3rd Support Level 63.20

See More

52-Week High 93.25
Fibonacci 61.8% 78.30
Fibonacci 50% 73.68
Fibonacci 38.2% 69.06
Last Price 66.46
52-Week Low 54.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar